axelvento
dCellVax
- Registrato
- 21/12/04
- Messaggi
- 16.246
- Punti reazioni
- 419
$ 1.29 ▲1.242 (2,587.50%)
Volume: 1,942,433
09/11/2009 (15:04 ET) VRMLQ: FDA Approval of OVA1(TM) Test for Ovarian Cancer - Knobias
VRMLQ: FDA Approval of OVA1(TM) Test for Ovarian Cancer
Friday , September 11, 2009 15:04ET
By Fain Hughes, fhughes@knobias.com
http://www.knobias.com/story.htm?ei...81faa8d042cc9b96fd6e1a877c1f88150bfebdae4d3b5
http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ
The U.S. FDA today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy. The test was developed by Vermillion, Inc. (VRMLQ), in cooperation with Quest Diagnostics (DGX).
Quest Diagnostics, which is a long-time investor in research and development of the OVA1 technology, has exclusive rights to offer the test to the clinical reference laboratory market in the U.S. for three years.
Public Companies Associated with this story:
DGX VRMLQ
Knobias Subject Codes Associated with this story:
FDA/R&D Important Co. News Major Agreements
Content transmitted by Knobias.com Copyright © 2009 Visit Knobias.com
http://www.knobias.com/story.htm?ei...81faa8d042cc9b96fd6e1a877c1f88150bfebdae4d3b5
http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ
ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER
Copyright © 2009 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.
Stop By And Visit Me At The SmallCap Trading Techniques Board
http://investorshub.advfn.com/boards/board.aspx?board_id=4203
Valuable Trading Ideas to help you make more MOMO!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41228203
Volume: 1,942,433
09/11/2009 (15:04 ET) VRMLQ: FDA Approval of OVA1(TM) Test for Ovarian Cancer - Knobias
VRMLQ: FDA Approval of OVA1(TM) Test for Ovarian Cancer
Friday , September 11, 2009 15:04ET
By Fain Hughes, fhughes@knobias.com
http://www.knobias.com/story.htm?ei...81faa8d042cc9b96fd6e1a877c1f88150bfebdae4d3b5
http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ
The U.S. FDA today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy. The test was developed by Vermillion, Inc. (VRMLQ), in cooperation with Quest Diagnostics (DGX).
Quest Diagnostics, which is a long-time investor in research and development of the OVA1 technology, has exclusive rights to offer the test to the clinical reference laboratory market in the U.S. for three years.
Public Companies Associated with this story:
DGX VRMLQ
Knobias Subject Codes Associated with this story:
FDA/R&D Important Co. News Major Agreements
Content transmitted by Knobias.com Copyright © 2009 Visit Knobias.com
http://www.knobias.com/story.htm?ei...81faa8d042cc9b96fd6e1a877c1f88150bfebdae4d3b5
http://www.knobias.com/individual/public/quote.htm?ticker=VRMLQ
ABOUT | PARTNERS | ADVERTISING INFO | CONTACT US | COPYRIGHT | PRIVACY | LEGAL | DISCLAIMER
Copyright © 2009 Knobias.Com, LLC. All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Knobias.Com, LLC, nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Knobias.Com website(s), a user agrees not to redistribute the information found therein. Knobias.Com, LLC is not a registered broker-dealer and does not endorse or recommend any securities listed herein or any services of any brokerage company.
Stop By And Visit Me At The SmallCap Trading Techniques Board
http://investorshub.advfn.com/boards/board.aspx?board_id=4203
Valuable Trading Ideas to help you make more MOMO!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=41228203
